clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Walgreens Dives into Gene and Cell Therapy Delivery
Oncology
A Newly Discovered Tumor Mechanism Could Improve Immunotherapies
Oncology
Annual Multi-Omics Test Spots Pancreatic Cancer
Oncology
Removing Notch Ligand, Jagged2, Rewires the Immune System to Eliminate NSCLC
Oncology
Day One’s Targeted Treatment for Most Common Kid’s Brain Tumor Approved
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Home
Topics
Oncology
Page 181
Oncology
Molecular Dx
Foundation Medicine CEO Cindy Perettie’s Top ASCO 2019 Takeaways
Chris Anderson
-
June 12, 2019
0
Molecular Dx
Disrupted Microbiome Aids Spread of Breast Cancer
Chris Anderson
-
June 11, 2019
0
News & Features
New Drug Could Improve Response to Chemotherapy
Malorye Branca
-
June 6, 2019
0
News & Features
Pancreatic Cancer Patients with BRCA1/BRCA2 Respond to PARP Inhibitor
Malorye Branca
-
June 3, 2019
0
News & Features
Pre-Surgical Immunotherapy for Lung Cancer Shows Positive Results
Clinical OMICs Staff Writer
-
June 3, 2019
0
Molecular Dx
GRAIL’s Multi-Cancer Early Detection Blood Test Delivers Positive Results
Malorye Branca
-
June 1, 2019
0
Informatics
Tempus Attracts $200M in Series F Financing, Bringing Total Raised to $510M
Alex Philippidis
-
May 31, 2019
0
Molecular Dx
Bayer, Foundation Medicine to Develop NGS-Based Pan-Cancer CDx
Chris Anderson
-
May 31, 2019
0
Molecular Dx
Not if. When: Metabolomics’ Impact in Cancer Treatments May be Just Around the Corner
Julianna LeMieux, PhD
-
May 30, 2019
0
Molecular Dx
Thrive Launches with $110M and Johns Hopkins-developed Cancer Liquid Biopsy Tech
Alex Philippidis
-
May 30, 2019
0
1
...
180
181
182
...
243
Page 181 of 243
Related Content
Annual Multi-Omics Test Spots Pancreatic Cancer
Liver-Derived Protein Shows Potential as Therapeutic Target for Cancer
Deep Learning Could Improve Esophageal Cancer Screening
Breakthrough Imaging Approved for Residual Breast Cancer Detection after Lumpectomy
Inside Precision Medicine
![A three-protein biomarker panel has been established that is able to screen urine samples for signs of early-stage pancreatic cancer. [iStock/© David Marchal]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/289.jpeg "Pancreatic Cancer Patients with BRCA1/BRCA2 Respond to PARP Inhibitor")
